The biopharmaceutical industry is demonstrating a significant and counterintuitive trend in 2025, with companies increasingly channeling investments into European-based contract…
Read More

The biopharmaceutical industry is demonstrating a significant and counterintuitive trend in 2025, with companies increasingly channeling investments into European-based contract…
Read More
The burgeoning field of cell and gene therapy, heralded as a revolutionary frontier in medicine, is currently grappling with a…
Read More
Quintessence Biotech has introduced a pioneering bio-separation tool, dubbed DACS (Dynamic Artificial Cell System), designed to significantly alleviate the manufacturing…
Read More
A collaborative research team from Hiroshima University and Mitsubishi Materials Hardmetal Corporation has pioneered a novel additive manufacturing (AM) technique…
Read More